Stevens-Johnson Syndrome–Like Reaction After Exposure to Pembrolizumab and Recombinant Zoster Vaccine in a Patient With Metastatic Lung Cancer
Stevens-Johnson syndrome (SJS) is a life-threating mucocutaneous reaction predominantly induced by drugs. Targeted cancer therapies such as pembrolizumab, which has been approved for the treatment of metastatic malignancy, can cause severe skin toxicities, including SJS. They are rare and inconsiste...
Main Authors: | Ivy Riano MD, Cagney Cristancho MD, Thomas Treadwell MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-03-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/2324709620914796 |
Similar Items
Similar Items
-
Atypical Stevens–Johnson syndrome caused by pembrolizumab in the treatment of metastatic melanoma – Are corticosteroids a safe treatment option?
by: Cathal O'Connor, et al.
Published: (2020-01-01) -
A Case of Guillain-Barré Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrosis Overlap After Pembrolizumab Treatment
by: Tomoyo Oguri MD, PhD, et al.
Published: (2021-08-01) -
Stevens-Johnson Syndrome and Severe Anaemia: A Case of Toxicity Induced by Vemurafenib plus Cobimetinib following Pembrolizumab for Metastatic Melanoma
by: Tanja Batinac, et al.
Published: (2022-02-01) -
Stevens-Johnson Syndrome and Stroke Related to Mycoplasma
by: Sanjay K. Yadava MD, et al.
Published: (2022-01-01) -
STEVENS JOHNSON SYNDROME
by: Julia Fitriany, et al.
Published: (2019-07-01)